InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,927.60
(
-0.06%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
72.57
(
0.26%
)
Bitcoin
61,613.51
(
-0.09%
)
Post# of 253151
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 220075

Wednesday, 08/29/2018 11:19:20 AM

Wednesday, August 29, 2018 11:19:20 AM

Post# of 253151
ABBV braces for Humira FoBs in Europe:

https://finance.yahoo.com/news/europe-ready-cash-cheap-copies-132950407.html

Unlike ABBV’s patent estate in the US, which has enabled settlements that delay US Humira FoBs until 2023, ABBV’s Humira patents in European countries begin expiring in the next few months.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up